You are here

Federal laboratories are required by law to publish a notice of proposed exclusive licenses of available technologies. The purpose of the publication is to provide an opportunity for public comment. Comments generally must be received within 15 days from the publication date of the notice. Comments are submitted directly to the federal laboratory and will be reviewed accordingly.
 
Army Research Laboratory (ARL)
Nov 02, 2021

DEPARTMENT OF DEFENSE

Department of the Army

Notice of Intent to Grant Exclusive Patent License to Centimani, LLC; San Diego, CA

AGENCY: Department of the Army, DoD.

ACTION: Notice of Intent.
SUMMARY: The Department of the Army hereby gives notice of its.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Oct 15, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to LucyDx, LLC, 651 N. Broad St., Ste. 205 #4847, Middletown, DE 19709, USA, an exclusive license to international patent filing application no..[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Oct 04, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to SteroTherapeutics LLC, 3805 Old Easton Road Doylestown, Pennsylvania, 18902, USA, an exclusive license to international patent filing.[more]

U.S. Forest Service (FS) - Forest Products Laboratory (FPL)
Aug 26, 2021

Notice is hereby given that the U.S. Department of Agriculture, Forest Service, intends to grant to TAF Composites USA LLC, c/o Delaware Corporate Services Inc., Wilmington, Delaware, an exclusive license to U.S. Patent Application No. 15/896,265, “LIGNIN-BASED CARBON FOAMS AND COMPOSITES AND.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 26, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to offer to Fillauer Companies, Inc., 210 Amnicola Highway, Chattanooga, TN 37406, an exclusive license to U.S. Patent Nos. 9,549,827; 10,105,243; 10,376,.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 19, 2021

The present invention provides methods of treating an auditory impairment associated with outer hair cells of the cochlea in a subject. The method may comprise administering to said subject an effective amount of a composition comprising, as an active agent, an oligonucleotide sequence having a.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 19, 2021

A mask can comprise a covering material that is sufficiently sized to extend over a mouth and a
nose on a head of a wearer. The covering material can have an outer surface and an inner
surface. The covering material can define an opening therethrough. At least one transparent
.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 16, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to offer to Apex Foot Health Industries, 400 Frank W. Burr Blvd. Suite #240, Teaneck, NJ 07666, an exclusive license to VA’s rights in US Patent Nos. 10,.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Aug 16, 2021

Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to offer to ResQ Pharma, Inc., 2242 W. Harrison St., Ste. 201, Chicago, Illinois 60612, an exclusive license to VA’s rights in International Patent.[more]

Department of Veterans Affairs, Office of Research and Development (VA)
Jul 22, 2021

VA intends to offer Avanzarx Pharmaceutical Holdings, LLC an exclusive license to technology called "Treatment of Pulmonary Fibrosis using NEU1 Salidase Inhibitors" by Goldblum et al., VA ID 2019-175[more]

Pages